Comparative efficacy and safety of fenofibrate/pravastatin plus ezetimibe triple therapy and simvastatin/ezetimibe dual therapy in type 2 diabetic patients with mixed hyperlipidaemia and cardiovascular disease
Publication
, Journal Article
Farnier, M; Retterstøl, K; Steinmetz, A; Császár, A
Published in: Diabetes and Vascular Disease Research
July 2012
Duke Scholars
Published In
Diabetes and Vascular Disease Research
DOI
EISSN
1752-8984
ISSN
1479-1641
Publication Date
July 2012
Volume
9
Issue
3
Start / End Page
205 / 215
Publisher
SAGE Publications
Related Subject Headings
- Endocrinology & Metabolism
- 3202 Clinical sciences
- 1116 Medical Physiology
- 1115 Pharmacology and Pharmaceutical Sciences
- 1103 Clinical Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Farnier, M., Retterstøl, K., Steinmetz, A., & Császár, A. (2012). Comparative efficacy and safety of fenofibrate/pravastatin plus ezetimibe triple therapy and simvastatin/ezetimibe dual therapy in type 2 diabetic patients with mixed hyperlipidaemia and cardiovascular disease. Diabetes and Vascular Disease Research, 9(3), 205–215. https://doi.org/10.1177/1479164111430715
Farnier, Michel, Kjetil Retterstøl, Armin Steinmetz, and Albert Császár. “Comparative efficacy and safety of fenofibrate/pravastatin plus ezetimibe triple therapy and simvastatin/ezetimibe dual therapy in type 2 diabetic patients with mixed hyperlipidaemia and cardiovascular disease.” Diabetes and Vascular Disease Research 9, no. 3 (July 2012): 205–15. https://doi.org/10.1177/1479164111430715.
Farnier M, Retterstøl K, Steinmetz A, Császár A. Comparative efficacy and safety of fenofibrate/pravastatin plus ezetimibe triple therapy and simvastatin/ezetimibe dual therapy in type 2 diabetic patients with mixed hyperlipidaemia and cardiovascular disease. Diabetes and Vascular Disease Research. 2012 Jul;9(3):205–15.
Farnier, Michel, et al. “Comparative efficacy and safety of fenofibrate/pravastatin plus ezetimibe triple therapy and simvastatin/ezetimibe dual therapy in type 2 diabetic patients with mixed hyperlipidaemia and cardiovascular disease.” Diabetes and Vascular Disease Research, vol. 9, no. 3, SAGE Publications, July 2012, pp. 205–15. Crossref, doi:10.1177/1479164111430715.
Farnier M, Retterstøl K, Steinmetz A, Császár A. Comparative efficacy and safety of fenofibrate/pravastatin plus ezetimibe triple therapy and simvastatin/ezetimibe dual therapy in type 2 diabetic patients with mixed hyperlipidaemia and cardiovascular disease. Diabetes and Vascular Disease Research. SAGE Publications; 2012 Jul;9(3):205–215.
Published In
Diabetes and Vascular Disease Research
DOI
EISSN
1752-8984
ISSN
1479-1641
Publication Date
July 2012
Volume
9
Issue
3
Start / End Page
205 / 215
Publisher
SAGE Publications
Related Subject Headings
- Endocrinology & Metabolism
- 3202 Clinical sciences
- 1116 Medical Physiology
- 1115 Pharmacology and Pharmaceutical Sciences
- 1103 Clinical Sciences